Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Febuxostat vs allopurinol in primary gout with hyperuricemia
CTR20140082Phase 2Active
- Sponsor
- Nanjing Haina Pharmaceutical Technology
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of febuxostat in idiopathic gout, hyperuricemia, sponsored by Nanjing Haina Pharmaceutical Technology. Started May 2014; status: active.
02
Drugs
febuxostat
03
Conditions
idiopathic gouthyperuricemia
Beyond the preview
Go deeper on CTR20140082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140082.